Old Web
English
Sign In
Acemap
>
Paper
>
231P Prognosis and efficacy of frontline treatment for HR+ HER2- metastatic breast cancer occurring in gBRCA1/2 carriers
231P Prognosis and efficacy of frontline treatment for HR+ HER2- metastatic breast cancer occurring in gBRCA1/2 carriers
2021
J-S Frenel
Amélie Lusque
S. Delaloge
J.M. Ferrero
Thomas Bachelot
I Desmoulins
Christine Levy
J.-C. Eymard
A. Gonçalves
Anne Patsouris
M-A Mouret-Reynier
M. Leheurteur
Thierry Petit
Luc Cabel
Lionel Uwer
Marc Debled
Michaël Chevrot
Audrey Mailliez
William Jacot
T. de La Motte Rouge
Keywords:
Oncology
Internal medicine
Metastatic breast cancer
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]